Pediatricians' perceptions of and preferred timing for pediatric palliative care

Lindsay A Thompson1, Caprice Knapp, Vanessa Madden

  • 1Department of Pediatrics, College of Medicine, University of Florida, 1701 SW 16th Ave, Room 2103, Gainesville, FL 32608, USA. lathompson@peds.ufl.edu

Pediatrics
|May 1, 2009
PubMed

Insights

Pediatricians often equate palliative care with hospice, leading to late referrals for children with life-limiting illnesses. A broader definition emphasizing comprehensive services may improve early access to palliative care.

Area of Science:

  • Pediatric Palliative Care
  • Healthcare Provider Perceptions
  • Life-Limiting Illnesses

Background:

  • Pediatric palliative care aims to improve quality of life for children with serious illnesses.
  • Current recommendations advocate for early referral to palliative care services.
  • Understanding pediatrician perspectives is crucial for optimizing care delivery.

Purpose of the Study:

  • To examine pediatricians' definitions of palliative care.
  • To assess pediatrician preferences for referral timing in pediatric palliative care.
  • To identify factors influencing referral practices for children with life-limiting diseases.

Main Methods:

  • A survey was distributed to a random sample of 800 pediatricians in Florida and California.
  • Data were collected via mail and online surveys.
  • Descriptive and multivariate regression analyses were employed to analyze the data.

Main Results:

  • Pediatricians held diverse definitions of palliative care, with many equating it to hospice care.
  • Less than half of surveyed pediatricians had referred patients to palliative care.
  • There was no consensus on referral timing for various life-limiting pediatric diseases.

Conclusions:

  • Most pediatricians perceive palliative care as synonymous with hospice, resulting in delayed referrals.
  • A more inclusive definition of palliative care, encompassing a range of services, is needed.
  • Adopting a broader definition could facilitate earlier palliative care referrals for children with life-limiting conditions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...